BRPI0918530A2 - excipiente para formação de comprimidos baseado em lactose e celulose. - Google Patents
excipiente para formação de comprimidos baseado em lactose e celulose.Info
- Publication number
- BRPI0918530A2 BRPI0918530A2 BRPI0918530A BRPI0918530A BRPI0918530A2 BR PI0918530 A2 BRPI0918530 A2 BR PI0918530A2 BR PI0918530 A BRPI0918530 A BR PI0918530A BR PI0918530 A BRPI0918530 A BR PI0918530A BR PI0918530 A2 BRPI0918530 A2 BR PI0918530A2
- Authority
- BR
- Brazil
- Prior art keywords
- lactose
- cellulose based
- tabletting excipient
- based tabletting
- excipient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102008047910.1 | 2008-09-19 | ||
| DE102008047910A DE102008047910A1 (de) | 2008-09-19 | 2008-09-19 | Tablettierhilfsstoff auf Laktose- und Cellulosebasis |
| PCT/EP2009/062203 WO2010031866A1 (de) | 2008-09-19 | 2009-09-21 | Tablettierhilfsstoff auf laktose- und cellulosebasis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI0918530A2 true BRPI0918530A2 (pt) | 2015-12-08 |
| BRPI0918530B1 BRPI0918530B1 (pt) | 2019-06-04 |
Family
ID=41413349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0918530-5A BRPI0918530B1 (pt) | 2008-09-19 | 2009-09-21 | Granulado, seu uso e seu processo de produção, e composição. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8663684B2 (pt) |
| EP (1) | EP2344197B1 (pt) |
| KR (1) | KR101661256B1 (pt) |
| CN (1) | CN102202691B (pt) |
| BR (1) | BRPI0918530B1 (pt) |
| CA (1) | CA2737380C (pt) |
| DE (1) | DE102008047910A1 (pt) |
| ES (1) | ES2624231T3 (pt) |
| MX (1) | MX337357B (pt) |
| NZ (1) | NZ592331A (pt) |
| UA (1) | UA102865C2 (pt) |
| WO (1) | WO2010031866A1 (pt) |
| ZA (1) | ZA201101982B (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102008047910A1 (de) | 2008-09-19 | 2010-03-25 | Molkerei Meggle Wasserburg Gmbh & Co. Kg | Tablettierhilfsstoff auf Laktose- und Cellulosebasis |
| CN102258495B (zh) * | 2011-07-13 | 2013-01-30 | 石家庄四药有限公司 | 头孢丙烯片及其制备方法 |
| BR112014015923B1 (pt) * | 2011-12-27 | 2022-02-01 | Amgen (Europe) GmbH | Comprimidos revestidos de (+)-2-[1-(3-etoxi-4-metoxi-fenil)-2-metano-sulfoniletil]-4 - acetilaminoisoindolina-1,3-diona |
| JP6356684B2 (ja) | 2012-11-02 | 2018-07-11 | マレイ・アンド・プール・エンタープライゼズ・リミテッド | コルヒチン誘導体の投与による心血管イベントの処置または予防 |
| BR112015026418B1 (pt) | 2013-04-16 | 2022-10-04 | Murray And Poole Enterprises Limited | Formulação de liberação prolongada de colchicina e uso da referida formulação de liberação prolongada de colchicina |
| CR20230266A (es) * | 2020-12-18 | 2023-07-19 | Daewoong Pharmaceutical Co Ltd | Nueva formulación para administración oral, que comprende 1-(5-(2,4-difluorofenil)-1-((3-fluorofenil)sulfonil)-4-metoxi-1h-pirrol-3-il)-n-metilmetanamina |
| CN115226896A (zh) * | 2021-04-22 | 2022-10-25 | 张婧 | 糖类缓释组合物及其制备方法 |
| CN114504559B (zh) * | 2022-03-01 | 2023-05-05 | 安徽山河药用辅料股份有限公司 | 一种药用辅料乳糖纤维素共处理物的制备方法 |
| EP4591722A1 (en) * | 2022-09-21 | 2025-07-30 | Zhejiang Hanmai Pharmaceutical Technology Co., Ltd. | Saccharide sustained-release composition and preparation method therefor |
| EP4687846A1 (en) | 2023-03-28 | 2026-02-11 | RUPP, Thomas | Process for the production of a granulate and a granulate, in particular a granulate compound of excipients |
| EP4696303A1 (en) | 2024-08-14 | 2026-02-18 | Bonutra AG | All natural granulate |
Family Cites Families (93)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3045488A1 (de) | 1980-12-03 | 1982-07-01 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von stabilisierten kallikreinhaltigen tabletten |
| DE3505433A1 (de) * | 1985-02-16 | 1986-08-21 | Basf Ag, 6700 Ludwigshafen | Direkttablettierhilfsmittel |
| DE3506276C1 (de) | 1985-02-22 | 1986-04-24 | Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring | Direkttablettiermittel |
| DD249186A1 (de) | 1986-05-26 | 1987-09-02 | Univ Halle Wittenberg | Herstellungsverfahren einer neuen glibenclamid-arzneiform mit hoher bioverfuegbarkeit |
| ES2105368T3 (es) | 1993-02-11 | 1997-10-16 | Hoechst Ag | Procedimiento para la fabricacion de componentes ceramicos de nitruro de silicio, densamente sinterizados, con alta resistencia mecanica. |
| CZ289649B6 (cs) | 1994-07-22 | 2002-03-13 | Krka, Tovarna Zdravil. P.O. | Pevné lékové formy se spolehlivým uvolňováním aktivní sloľky alprazolamu a způsob jejich přípravy |
| DE19602757A1 (de) | 1996-01-26 | 1997-07-31 | Boehringer Mannheim Gmbh | Feste Instant-Release-Darreichungsformen und Verfahren zu ihrer Herstellung |
| AU2068797A (en) | 1996-01-29 | 1997-08-20 | Edward Mendell Co. Inc. | Sustained release excipient |
| US5762961A (en) | 1996-02-09 | 1998-06-09 | Quadrant Holdings Cambridge Ltd. | Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof |
| DE19651734C2 (de) | 1996-12-12 | 1999-05-12 | Dds Drug Delivery Service Ges | Zubereitung in Form eines Polymer-Hilfsstoff-Compounds und/oder eines Polymer-Wirkstoff-Compounds und Verfahren zu dessen Herstellung sowie dessen Verwendung zur Herstellung von Tabletten und/oder anderen größeren Matrixeinheiten |
| DE19749897C1 (de) | 1997-11-12 | 1999-08-26 | Dds Drug Delivery Service Ges | Zubereitung in Form eines Lipid-Hilfsstoff-Compounds und/oder eines Lipid-Wirkstoff-Compounds und Verfahren zu dessen Herstellung sowie dessen Verwendung zur Herstellung von Tabletten und/oder anderen größeren Matrixeinheiten |
| EP0948321B1 (de) | 1996-12-12 | 2003-10-22 | Dds Drug Delivery Service Gesellschaft Zur Förderung Der Forschung In Pharmazeutischer Technologie Und Biopharmazie Mbh | Zubereitung in form eines wahlweise wirkstoffhaltigen matrixmaterial-hilfsstoff compounds |
| CA2209868C (en) | 1997-08-15 | 2001-08-14 | Bernard Charles Sherman | Pharmaceutical compositions comprising cefuroxime axetil |
| PL340305A1 (en) | 1997-11-03 | 2001-01-29 | Janssen Pharmaceutica Nv | Composition of agents reducing the level of lipoides |
| US6168805B1 (en) | 1998-05-07 | 2001-01-02 | Endo Pharmaceuticals, Inc. | Aqueous process for manufacturing paroxetine solid dispersions |
| CO5070643A1 (es) | 1998-05-27 | 2001-08-28 | Merck & Co Inc | Formulacion en tabletas comprimidas |
| EP1332757B1 (en) | 1998-05-27 | 2012-06-13 | Merck Sharp & Dohme Corp. | Efavirenz compressed tablet formulation |
| MA26693A1 (fr) | 1998-09-28 | 2004-12-20 | Glaxo Group Ltd | Compositions pour administration par voie buccale |
| US6579953B1 (en) | 1998-09-30 | 2003-06-17 | Basf Aktiengesellschaft | Application of water-soluble or water-dispersible polymerizates which contain poly-ether and which are used as a coating agent, a binding agent and/or as a film-forming auxiliary agent in pharmaceutical forms of administration |
| US20040013613A1 (en) | 2001-05-18 | 2004-01-22 | Jain Rajeev A | Rapidly disintegrating solid oral dosage form |
| IL143197A0 (en) | 1998-11-20 | 2002-04-21 | Rtp Pharma Inc | Dispersible phospholipid stabilized microparticles |
| US6716453B1 (en) | 1999-05-20 | 2004-04-06 | Verion, Inc. | Method for increasing the active loading of compressible composition forms |
| HUP0201307A2 (hu) | 1999-06-11 | 2002-11-28 | Ranbaxy Laboratories Limited | Ízfedett gyógyszerkészítmények |
| UA72922C2 (uk) | 1999-08-03 | 2005-05-16 | Ліллі Айкос Ллк | ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ З <font face="Symbol">b</font>-КАРБОЛІНОМ (ВАРІАНТИ) ТА СПОСІБ ЛІКУВАННЯ СЕКСУАЛЬНОЇ ДИСФУНКЦІЇ |
| US6419956B1 (en) | 1999-12-30 | 2002-07-16 | Ancile Pharmaceuticals | Odor-masking coating for a pharmaceutical preparation |
| EP1136254B1 (de) | 2000-03-23 | 2003-05-28 | BASF Drucksysteme GmbH | Verwendung von Pfropfcopolymeren zur Herstellung lasergravierbarer Reliefdruckelementen |
| US6761901B1 (en) | 2000-05-02 | 2004-07-13 | Enzrel Inc. | Liposome drug delivery |
| US6316029B1 (en) | 2000-05-18 | 2001-11-13 | Flak Pharma International, Ltd. | Rapidly disintegrating solid oral dosage form |
| US20020001617A1 (en) | 2000-05-26 | 2002-01-03 | Chang-Hyun Lee | Rapidly disintegrating tablet and process for the manufacture thereof |
| US6413590B1 (en) | 2000-05-31 | 2002-07-02 | Rexam Graphics Inc. | Glossy ink jet medium |
| WO2002002083A1 (en) | 2000-06-30 | 2002-01-10 | Yamanouchi Pharmaceutical Co., Ltd. | Tablet rapidly disintegrating in mouth and process for producing the same |
| JP2004514419A (ja) | 2000-07-13 | 2004-05-20 | ビタテネ、ソシエダッド アノニマ | カロチノイドを含有する水分散性配合物の製造方法 |
| EP1175899B1 (fr) | 2000-07-27 | 2007-08-29 | Roquette FrÀ¨res | Granules à base d'amidon et de lactose |
| IN192750B (pt) | 2000-12-15 | 2004-05-15 | Ranbaxy Lab Ltd | |
| US6720003B2 (en) | 2001-02-16 | 2004-04-13 | Andrx Corporation | Serotonin reuptake inhibitor formulations |
| US6610326B2 (en) | 2001-02-16 | 2003-08-26 | Andrx Corporation | Divalproex sodium tablets |
| SE0101329D0 (sv) | 2001-04-12 | 2001-04-12 | Astrazeneca Ab | Pharmaceutical formulation |
| WO2002100407A1 (en) | 2001-06-12 | 2002-12-19 | Smartrix Technologies Inc. | Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing same |
| DE60220695T2 (de) | 2001-09-04 | 2007-10-18 | Dow Global Technologies, Inc., Midland | Verfahren zum dispergieren eines fluidums in feststoffpartikeln |
| JP2005506323A (ja) | 2001-09-05 | 2005-03-03 | ベクトゥラ・リミテッド | 経口送達用機能性散剤 |
| DE10152351B4 (de) | 2001-10-18 | 2005-09-22 | Schering Ag | Feste Arzneimittelformulierung für ein Piperazinharnstoffderivat |
| US6753017B2 (en) | 2001-11-07 | 2004-06-22 | Jrs Pharma Lp | Process for preparing dry extracts |
| EP1481211B1 (en) | 2001-11-29 | 2009-04-22 | J. Rettenmaier & Söhne GmbH + Co. KG | Process for co-spray drying liquid herbal extracts with dry silicified mcc |
| US20030206978A1 (en) | 2001-11-29 | 2003-11-06 | Bob Sherwood | Agglomerated particles including an active agent coprocessed with silicified microcrystalline cellulose |
| US7179488B2 (en) | 2001-11-29 | 2007-02-20 | Bob Sherwood | Process for co-spray drying liquid herbal extracts with dry silicified MCC |
| EP1509204A4 (en) | 2001-11-29 | 2005-07-13 | Rettenmaier & Soehne Gmbh & Co | AGGLOMERATED PARTICLES WITH AN ACTIVE SUBSTANCE PREPARED WITH MELTED MICROCRYSTALLINE CELLULOSE |
| JP4477354B2 (ja) | 2002-01-10 | 2010-06-09 | ルピン・リミテッド | 乾癬を含む様々な疾患を処置するための薬草組成物、その調製方法およびそのような疾患を処置するための方法 |
| DE10207427A1 (de) | 2002-02-21 | 2003-09-04 | Basf Ag | Schnelllöslicher Filmüberzug basierend auf Polyvinylalkohol-Polyether-Pfropfcopolymeren in Kombination mit Hydroxy-, Amid-, oder Esterfunktionen enthaltenden Komponenten |
| JP4790219B2 (ja) | 2002-03-26 | 2011-10-12 | ユーロ−セルティーク エス．エイ． | 徐放性ゲルコーティング組成物 |
| AU2003238670A1 (en) | 2002-04-05 | 2003-10-27 | Cadila Healthcare Limited | Fast disintegrating oral dosage forms |
| MY128945A (en) * | 2002-04-16 | 2007-03-30 | Kowa Co | Solid dispersion composition |
| HRP20041092B1 (hr) | 2002-05-22 | 2013-05-31 | Boehringer Ingelheim Pharma Gmbh & Co.Kg | Novi farmaceutski pripravci flibanserina |
| US20040037869A1 (en) | 2002-08-16 | 2004-02-26 | Douglas Cleverly | Non-animal product containing veterinary formulations |
| GB0219516D0 (en) | 2002-08-21 | 2002-10-02 | Phoqus Ltd | Fast dissolving and taste masked oral dosage form comprising sildenafil |
| US20040097484A1 (en) | 2002-11-14 | 2004-05-20 | Marc Cantillion | Once a day galantamine pharmaceutical compositions and methods of use |
| ES2280835T3 (es) | 2002-12-19 | 2007-09-16 | Pharmacia Corporation | Formulacion no higroscopica que comprende un farmaco higroscopico. |
| CA2510786C (en) | 2002-12-19 | 2012-02-07 | Council Of Scientific And Industrial Research | Antiulcer herbal composition(s) |
| AU2002353414A1 (en) | 2002-12-30 | 2004-07-22 | Council Of Scientific And Industrial Research | Development of an anti-cough, anti-tussive and throat soothing herbal formulation |
| WO2004066982A1 (en) | 2003-01-31 | 2004-08-12 | Ranbaxy Laboratories Limited | Stable oral benzimidazole compositions and processes for their preparation |
| EP1608341A1 (en) | 2003-03-21 | 2005-12-28 | Ranbaxy Laboratories, Ltd. | Water-soluble tablets of metformin |
| WO2004089343A1 (en) | 2003-04-09 | 2004-10-21 | Ranbaxy Laboratories Limited | Water soluble tablets |
| KR100503949B1 (ko) | 2003-04-28 | 2005-07-26 | 주식회사유한양행 | 염산 온단세트론의 쓴맛을 효과적으로 은폐한 경구용 구강속붕해정 조성물 |
| DE10319450A1 (de) | 2003-04-30 | 2004-11-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmazeutische Formulierung des Telmisartan Natriumsalzes |
| WO2005007105A2 (en) | 2003-07-10 | 2005-01-27 | Smithkline Beecham Corporation | Pharmaceutical compositions |
| TW200507882A (en) | 2003-07-17 | 2005-03-01 | Kyowa Hakko Kogyo Kk | Solid formulations |
| WO2005009407A2 (en) | 2003-07-29 | 2005-02-03 | Ranbaxy Laboratories Limited | Oral pharmaceutical formulations of olanzapine |
| KR100604034B1 (ko) | 2003-10-08 | 2006-07-24 | 주식회사유한양행 | 암로디핀 유리염기를 함유한 구강 속붕해정 및 그의 조성물 |
| WO2005041941A2 (en) | 2003-11-03 | 2005-05-12 | Zentiva, A.S. | Valsartan containing formulation |
| WO2005051489A2 (en) | 2003-11-28 | 2005-06-09 | Ranbaxy Laboratories Limited | Fast dissolving solid oral dosage forms of galanthamine |
| US20050142193A1 (en) | 2003-12-31 | 2005-06-30 | Lijuan Tang | Galantamine formulations |
| CA2551946A1 (en) | 2003-12-31 | 2005-07-21 | Actavis Group Hf | Immediate, controlled and sustained release formulations of galantamine |
| US20060222677A1 (en) | 2004-01-14 | 2006-10-05 | Bianca Baroli | Method of protecting sensitive molecules from a photo-polymerizing environment |
| WO2005082330A2 (en) | 2004-02-19 | 2005-09-09 | Ranbaxy Laboratories Limited | Co-precipitated amorphous cefditoren pivoxil and dosage forms comprising the same |
| WO2005082331A2 (en) | 2004-02-26 | 2005-09-09 | Ranbaxy Laboratories Limited | Extended release tablets of clarithromycin |
| EP1765300A2 (en) | 2004-06-10 | 2007-03-28 | Duramed Pharmaceuticals, Inc. | Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same |
| CN1968682A (zh) | 2004-06-18 | 2007-05-23 | 株式会社柳韩洋行 | 包含表面改性的碳酸氢钠的阿莫西林和/或克拉维酸口服分散片组合物 |
| US20060127479A1 (en) | 2004-10-08 | 2006-06-15 | Natrajan Kumaraperumal | Solvent free taste masked pharmaceutical compositions |
| WO2006101536A1 (en) | 2004-11-04 | 2006-09-28 | Akina, Inc. | Fast-melting tablets having taste-masking and sustained release properties |
| US20060159747A1 (en) | 2004-12-17 | 2006-07-20 | Boehringer Ingelheim International Gmbh | Telmisartan and hydrochlorothiazide combination therapy |
| EP1845949B1 (en) | 2005-02-03 | 2008-05-21 | Nycomed Pharma AS | Melt granulation of a composition containing a calcium-containing compound |
| CN101128189A (zh) | 2005-02-25 | 2008-02-20 | 弗·哈夫曼-拉罗切有限公司 | 药物物质分散性改善的片剂 |
| GB0504203D0 (en) | 2005-03-01 | 2005-04-06 | Novartis Ag | Organic compounds |
| JP2008536929A (ja) | 2005-04-18 | 2008-09-11 | ルビコン・リサーチ・ピーヴィーティー・エルティーディー | 生体強化組成物 |
| US20070014853A1 (en) | 2005-07-15 | 2007-01-18 | Ilan Zalit | Pharmaceutical dosage form containing novel pharmaceutical granulate |
| JP2009511627A (ja) | 2005-10-17 | 2009-03-19 | マリンクロッド・インコーポレイテッド | 錠剤マトリックスにおけるゾルピデムの多形転移 |
| UA95093C2 (uk) | 2005-12-07 | 2011-07-11 | Нікомед Фарма Ас | Спосіб одержання кальцієвмісної сполуки |
| RU2008136766A (ru) | 2006-02-24 | 2010-03-27 | Тева Фармасьютикл Индастриес Лтд. (Il) | Таблетки метопролола сукцината пролонгированного действия и способы их приготовления |
| WO2007096906A2 (en) | 2006-02-27 | 2007-08-30 | Panacea Biotec Ltd. | Novel buccoadhesive compositions and process of preparation thereof |
| GB0610570D0 (en) | 2006-05-27 | 2006-07-05 | Pliva Istrazivanje I Razvoj D | Novel formulation |
| CA2654402A1 (en) * | 2006-06-01 | 2007-12-06 | Adel Penhasi | Multiple unit pharmaceutical formulation |
| JP5160423B2 (ja) | 2006-07-19 | 2013-03-13 | 旭化成ケミカルズ株式会社 | 水易溶性薬物含有球状素顆粒の製造方法 |
| CN100438917C (zh) * | 2006-07-20 | 2008-12-03 | 山东聊城阿华制药有限公司 | 一种微晶纤维素乳糖的制备方法 |
| DE102008047910A1 (de) | 2008-09-19 | 2010-03-25 | Molkerei Meggle Wasserburg Gmbh & Co. Kg | Tablettierhilfsstoff auf Laktose- und Cellulosebasis |
-
2008
- 2008-09-19 DE DE102008047910A patent/DE102008047910A1/de not_active Withdrawn
-
2009
- 2009-09-21 CA CA2737380A patent/CA2737380C/en active Active
- 2009-09-21 KR KR1020117008931A patent/KR101661256B1/ko active Active
- 2009-09-21 EP EP09736157.0A patent/EP2344197B1/de active Active
- 2009-09-21 NZ NZ592331A patent/NZ592331A/xx unknown
- 2009-09-21 ES ES09736157.0T patent/ES2624231T3/es active Active
- 2009-09-21 US US13/119,945 patent/US8663684B2/en active Active
- 2009-09-21 UA UAA201104469A patent/UA102865C2/ru unknown
- 2009-09-21 BR BRPI0918530-5A patent/BRPI0918530B1/pt active IP Right Grant
- 2009-09-21 WO PCT/EP2009/062203 patent/WO2010031866A1/de not_active Ceased
- 2009-09-21 CN CN200980142138.2A patent/CN102202691B/zh active Active
- 2009-09-21 MX MX2011002950A patent/MX337357B/es active IP Right Grant
-
2011
- 2011-03-16 ZA ZA2011/01982A patent/ZA201101982B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010031866A1 (de) | 2010-03-25 |
| US8663684B2 (en) | 2014-03-04 |
| CN102202691A (zh) | 2011-09-28 |
| ES2624231T3 (es) | 2017-07-13 |
| DE102008047910A8 (de) | 2010-07-08 |
| BRPI0918530B1 (pt) | 2019-06-04 |
| UA102865C2 (ru) | 2013-08-27 |
| EP2344197A1 (de) | 2011-07-20 |
| CA2737380C (en) | 2017-04-11 |
| MX2011002950A (es) | 2011-08-03 |
| CA2737380A1 (en) | 2010-03-25 |
| DE102008047910A1 (de) | 2010-03-25 |
| ZA201101982B (en) | 2011-11-30 |
| KR20110063549A (ko) | 2011-06-10 |
| KR101661256B1 (ko) | 2016-09-30 |
| NZ592331A (en) | 2012-10-26 |
| MX337357B (es) | 2016-02-29 |
| US20110207826A1 (en) | 2011-08-25 |
| EP2344197B1 (de) | 2017-04-05 |
| CN102202691B (zh) | 2014-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0918530A2 (pt) | excipiente para formação de comprimidos baseado em lactose e celulose. | |
| BR112012002955A2 (pt) | estruturas fibrosas e métodos de fabricação das mesmas. | |
| BRPI0814467A2 (pt) | Método, e, biocombustível | |
| BRPI0813011A2 (pt) | Formulação injetável aquosa estéril, processo de preparação da mesma e sua utilização | |
| EP2265196A4 (en) | ELECTRO-SURGICAL SYSTEM | |
| BRPI0916756A2 (pt) | sistemas e métodos para anestesiar o tecido auricular. | |
| BRPI0913227A2 (pt) | método, e objeto | |
| BRPI0906957A2 (pt) | Aerogéis de carbono, processo para a sua preparação e seu uso | |
| BRPI0923852A2 (pt) | verificação de identidade unificada | |
| IT1397663B1 (it) | Bocchettone e procedimento per la sua fabbricazione. | |
| BRPI1014765A2 (pt) | microesferas de amplificação de sinal, seu uso em procedimento de amplificação analítica de uma etapa e multietapa e métodos para sua produção. | |
| BRPI0921106A2 (pt) | biocombustível e processo para preparação de biocombustível | |
| BRPI0912504A2 (pt) | acoplamento de travamento de brecha | |
| DE602008005522D1 (de) | Polymerlösungen | |
| BRPI0914651A2 (pt) | conjunto de cunha e soquete | |
| BRPI0821652A2 (pt) | tratamento de biocombustíveis | |
| FI20086108L (fi) | Halkaisukiila | |
| BRPI0919761A2 (pt) | picador para fibras mescladas | |
| DE112008002346A5 (de) | Kompressionsverschluss | |
| EP2345660A4 (en) | ANTI-XDR-TB-MEDIUM, ANTI-MDR-TB-MEDIUM AND COMBINED ANTIBODY CLOUD | |
| BRPI0819297A2 (pt) | Sistemas e métodos de desidratação | |
| DE112008000217A5 (de) | Kompressions-Schwenkhebelverschluss | |
| HRP20150021T1 (xx) | Spojevi fenantrenona, pripravci i postupci | |
| DE112008000961A5 (de) | Kompressionsverschluss | |
| BRPI0820958A2 (pt) | Intermediário, e, composto |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 21/09/2009, OBSERVADAS AS CONDICOES LEGAIS. (CO) 20 (VINTE) ANOS CONTADOS A PARTIR DE 21/09/2009, OBSERVADAS AS CONDICOES LEGAIS |